视频标题

Emei Family Intelligent Robot

Good Assistant for Smart Total Lab

Pinnacles Intelligent Robot

Start a New Era for STLA


The intelligent robot cooperates with its core control system, based on comprehensive information technologies such as Artificial Intelligence, 5G, and the Internet of Things. Linking with LIS, middleware, and equipment's system, it will optimize processes of clinical laboratory, save labor cost, ensure biosecurity protection, improve operational efficiency, and construct a intelligent hospital.

MORE

Shanghai Pinnacles Medical Technology Co., Ltd. is committed to being a new generation of intelligent diagnosis IVD leading enterprise, integrating independent research and development, manufacturing, marketing and service, and is committed to solving the pain points and difficulties of current diagnosis with high-quality and forward-looking products. At present, it has established R&D and intellectual manufacturing centers in Shanghai, Shenzhen, Beijing, Zhengzhou, Suzhou, Hunan and other places to realize the integration of production and research.

MORE

Our Leadership

FOUNDER DIRECTORS
Richard Ding     Chair & CEO

Richard Ding Chair & CEO

Richard Ding , the founder of Pinnacles Medical Technology, is a senior expert in the global IVD industry and has won the honor of leading figure IVD in China. He has successively served as the Executive Committee Member and Asia-Pacific President of bioMérieux, and CEO of KHB, first li-sted China IVD company. As first ten employees of Myriad Genetics team that discovered and developed BRCA and Strategy and Biz Dev. at Eli Lilly and Company, he has served as an independent director in NASDAQ, and has led the mergers and acquisitions of more than a dozen companies at home and abroad, including Biofire, one of the most successful molecular diagnosis companies in the United States in the past decade, and Tianlong Technology in China. Majored in microbiology from Fudan University, master of Southern Illinois University, master of MBA from University of Utah, with strong ability to integrate domestic and foreign resources.

Gaopeng Chen  Member of the Board

Gaopeng Chen Member of the Board

Gaopeng Chen is former Vice President and Head of Healthcare at ZhenFund and focuses on early stage healthcare opportunities.Prior to joining ZhenFund, Gaopeng was an investment profession-al at Langsheng Investment. Gaopeng began his career at Eli Lilly China, where he participated in the development of multiple drugs.Gaopeng received a B.S. from Sichuan University and obtained a Ph.D. from LKS Faculty of Medicine, the University of Hong Kong. He also conducted research at the Icahn School of Medicine at Mount Sinai.

Our Investors

  • Lilly Asia Ventures

    Lilly Asia Ventures

    Lilly Asia Ventures (LAV) is a leading biomedi-cal venture capital firm, with offices in Shang-hai, Hong Kong, and Palo Alto. Originated in 2008 as a corporate venture subsidiary of Eli Lilly, we spun off and became an independent investment management company. Our vision is to become the trusted partner for exceptio-nal entrepreneurs seeking smart capital and to build great companies developing breakthrou-gh products that treat diseases and improve human health.
  • CTS Capital

    CTS Capital

    CTS Capital was founded in 2017. As a private equity firm, CTS Capital focuses on investment opportunities in the biotechnology and healt-hcare services industries. CTS Capital is mana-ged by a team of professionals with deep ind-ustry knowledge, extensive experiences in private equity and global strategic insights. Driven by our team's business acumen and investment expertise, CTS Capital has made investments in companies at the cutting edge of the biotechnology and healthcare industri-es, including innovative drugs, medical devic-es, diagnostics, gene technology, digital health and AI in healthcare, etc.
  • Oriental Fortune Capital

    Oriental Fortune Capital

    Shenzhen Oriental Fortune Capital Investment Management Co., Ltd. (OFC) is one of the lea-ding venture capital investment firms in China. Founded in 2006, OFC is currently managing 55 funds with assets totaling RMB 30 billion. OFC's medical funds aim to invest in compani-es with innovative products, advanced manu-facturing techniques, forwardlooking techno-logies, and featured operational models.
  • Vertex Ventures

    Vertex Ventures

    Vertex Ventures is a global network of venture capital funds. The operatorinvestors manage portfolios in China, the U.S., Israel, India and Southeast Asia. The firm is a trusted partner to some of the world’s most innovative entrepr-eneurs, supporting them with unmatched ope-rating experience and deep access to the capi-tal, talent, partners and customers they need to build truly global businesses.Vertex Ventures China, founded in 2008, has offices in Beijing, Shanghai and Shenzhen. It is currently managing both Dollar and RMB funds, with assets under management of over ¥10 billion.
  • ZhenFund

    ZhenFund

    ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental cofounders Bob Xiaoping Xu and Victor Qiang Wang establi-shed ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 10 unicorns based in China.
  • Asset Management

    Asset Management

    We keep looking for opportunities in the bio-tech, meditech and healthcare services indus-tries in China. Our investment decisions are made from a combination of expertise know-ledge and through industrywide, macroeco-nomic research effort. Our professional mana-gement team pursues perfection in industrial research, investments and postinvestment management. Our longterm investments focus on sustainable growth and development that can create the best value for our clients. We believe that only those investments can realize a high and stable return for our investors.
  • HealthCare Fund

    HealthCare Fund

    HealthCare Fund is a venture capital fund fou-nded by senior healthcare investment profess-ionals dedicated to early stage investments in the healthcare industry. Adhering to the conc-ept of “Focus and Professionalism”, we dig deeply into the development trend and invest-ment opportunities of the medical and health industry, remove noise and confusion, and pursue the truth.
  • CD Capital

    CD Capital

    Run by a group of healthcare industry veteran-s, CD Capital backs great entrepreneurs and disruptive companies that prevent, detect, and cure diseases, with venture funds and industry resources. We are managing multiple USD and RMB funds, with an AUM over $1 Billion, and have provided venture funds for more than 60 companies to achieve their full potential.
  • Sequoia Capital

    Sequoia Capital

    We partner early. We're comfortable with the rough imperfection of a new venture. We help founders from day zero, when the DNA of their business first takes shape. Our team partners both with young companies finding their stride and established ones looking for stepfunction growth. We help organizations become enduring businesses.
  • Lilly Asia Ventures
  • CTS Capital
  • Oriental Fortune Capital
  • Vertex Ventures
  • ZhenFund
  • Asset Management
  • HealthCare Fund
  • CD Capital
  • Sequoia Capital

Our Culture

Pinnacles

+Vision

Future Diagnostics Solutions For Today

+Orientation

New Generation IVD Company